Skip to main content
Clinical Trials/CTRI/2024/01/060989
CTRI/2024/01/060989Not yet recruitingPhase 3

A Randomized Controlled Trial to Evaluate the Effect of Daily Abhyanga with Balaswagandha Lakshadi Taila in Response inhibition Among Children with Hyperactivity.

Dr Arathi M Nair1 site in 1 country24 target enrollmentStarted: January 8, 2024Last updated:

Trial Snapshot

Phase
Phase 3
Status
Not yet recruiting
Sponsor
Enrollment
24
Locations
1
Primary Endpoint
•Response inhibition.

Study Overview

Brief Summary

The study is a Randomized Controlled Trial to evaluate the effect of Balaswagandha Lakshadi taila over Behaviour modification in Response Inhibition among children with Hyperactivity aged 7-12 years. Participants who meet the criteria for hyperactivity (who has a score above 15), as determined by the Conner’s Abbreviated Teacher rating scale will be separated into two group using simple random sampling technique. One group provided with behavioural modification and the other group with Abhyanga along with behavioural modification.

Study Design

Study Type
Interventional
Allocation
Randomized
Masking
None

Eligibility Criteria

Ages
7.00 Year(s) to 12.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Screened for hyperactivity using Conner Abbreviated Teacher Rating scale and selected subjects who has a score above 15 Consent from Parents / Guardian.

Exclusion Criteria

  • Children who are under medication for epilepsy.
  • Children who have asthma and experience repeated or frequent episodes of asthma attacks.
  • Children with skin disorders.

Outcomes

Primary Outcomes

•Response inhibition.

Time Frame: • At baseline, 3 months

Secondary Outcomes

  • Hyperactivity(at baseline, 3 months)

Investigators

Sponsor
Dr Arathi M Nair
Sponsor Class
Other [self]
Responsible Party
Principal Investigator
Principal Investigator

Dr Arathi M Nair

Amrita School of Ayurveda

Study Sites (1)

Loading locations...

Similar Trials